382 related articles for article (PubMed ID: 27037228)
1. Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort.
Lee WJ; Lee ST; Byun JI; Sunwoo JS; Kim TJ; Lim JA; Moon J; Lee HS; Shin YW; Lee KJ; Kim S; Jung KH; Jung KY; Chu K; Lee SK
Neurology; 2016 May; 86(18):1683-91. PubMed ID: 27037228
[TBL] [Abstract][Full Text] [Related]
2. Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: An Institutional Cohort Study.
Lee WJ; Lee ST; Moon J; Sunwoo JS; Byun JI; Lim JA; Kim TJ; Shin YW; Lee KJ; Jun JS; Lee HS; Kim S; Park KI; Jung KH; Jung KY; Kim M; Lee SK; Chu K
Neurotherapeutics; 2016 Oct; 13(4):824-832. PubMed ID: 27215218
[TBL] [Abstract][Full Text] [Related]
3. LGI1 antibody encephalitis: acute treatment comparisons and outcome.
Rodriguez A; Klein CJ; Sechi E; Alden E; Basso MR; Pudumjee S; Pittock SJ; McKeon A; Britton JW; Lopez-Chiriboga AS; Zekeridou A; Zalewski NL; Boeve BF; Day GS; Gadoth A; Burkholder D; Toledano M; Dubey D; Flanagan EP
J Neurol Neurosurg Psychiatry; 2022 Mar; 93(3):309-315. PubMed ID: 34824144
[TBL] [Abstract][Full Text] [Related]
4. Lower dosages of rituximab used successfully in the treatment of anti-NMDA receptor encephalitis without tumour.
Wang BJ; Wang CJ; Zeng ZL; Yang Y; Guo SG
J Neurol Sci; 2017 Jun; 377():127-132. PubMed ID: 28477682
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of rituximab on seizure control and cognitive symptoms in leucine-rich, glioma-inactivated 1 (LGI1) limbic encephalitis: a high-density electroencephalography case study.
Cheli M; Dinoto A; Tommasini V; Ajčević M; Stella G; Catalan M; Stokelj D; Sartori A; Manganotti P
Epileptic Disord; 2020 Oct; 22(5):678-682. PubMed ID: 33146142
[TBL] [Abstract][Full Text] [Related]
6. Clinical features, investigations, and outcomes of pediatric limbic encephalitis: A multicenter study.
Sabanathan S; Abdel-Mannan O; Mankad K; Siddiqui A; Das K; Carr L; Eltze C; Eyre M; Gadian J; Hemingway C; Kaliakatsos M; Kneen R; Krishnakumar D; Lynch B; Parida A; Rossor T; Taylor M; Wassmer E; Wright S; Lim M; Hacohen Y
Ann Clin Transl Neurol; 2022 Jan; 9(1):67-78. PubMed ID: 35015932
[TBL] [Abstract][Full Text] [Related]
7. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
[TBL] [Abstract][Full Text] [Related]
8. Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry.
Thaler FS; Zimmermann L; Kammermeier S; Strippel C; Ringelstein M; Kraft A; Sühs KW; Wickel J; Geis C; Markewitz R; Urbanek C; Sommer C; Doppler K; Penner L; Lewerenz J; Rößling R; Finke C; Prüss H; Melzer N; Wandinger KP; Leypoldt F; Kümpfel T;
Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34599001
[TBL] [Abstract][Full Text] [Related]
9. Psychiatric manifestations of anti-NMDA receptor encephalitis in a man without tumor.
Kung DH; Qiu C; Kass JS
Psychosomatics; 2011; 52(1):82-5. PubMed ID: 21300200
[No Abstract] [Full Text] [Related]
10. Immunotherapy for Refractory Autoimmune Encephalitis.
Yang J; Liu X
Front Immunol; 2021; 12():790962. PubMed ID: 34975890
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of rituximab in autoimmune encephalitis: A meta-analysis.
Nepal G; Shing YK; Yadav JK; Rehrig JH; Ojha R; Huang DY; Gajurel BP
Acta Neurol Scand; 2020 Nov; 142(5):449-459. PubMed ID: 32484900
[TBL] [Abstract][Full Text] [Related]
12. [Effectiveness and safety of rituximab for children with autoimmune diseases of the nervous system].
Fu Z; Bao XH; Wu Y; Zhou J; Zhang YH; Zhang Y; Ji TY; Chen Y
Zhonghua Er Ke Za Zhi; 2017 Sep; 55(9):689-694. PubMed ID: 28881516
[No Abstract] [Full Text] [Related]
13. Combination Treatment with Rituximab and Bortezomib in a Patient with Non-Paraneoplastic Autoimmune Retinopathy.
Benson MD; Plemel DJA; Yacyshyn E; Sandhu I; MacDonald IM; Baker CF
Ocul Immunol Inflamm; 2020 Aug; 28(6):958-965. PubMed ID: 31418623
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of rituximab therapy in patients with pemphigus vulgaris: first report from Turkey.
Uzun S; Bilgiç Temel A; Akman Karakaş A; Ergün E; Özkesici B; Eskiocak AH; Erat A; Uğurlu N; Nazlım B; Koç S; Bozkurt S; Dicle Ö; Alpsoy E; Yılmaz E
Int J Dermatol; 2016 Dec; 55(12):1362-1368. PubMed ID: 27653507
[TBL] [Abstract][Full Text] [Related]
15. "Limbic encephalitis with acute onset and Hu antibodies treated with rituximab: Paraneoplastic or non-paraneoplastic disorder?".
Lapucci C; Benedetti L; Tavarelli C; Serrati C; Godani M; Schenone A; Franciotta D
Clin Neurol Neurosurg; 2019 Sep; 184():105424. PubMed ID: 31330415
[TBL] [Abstract][Full Text] [Related]
16. Case records of the Massachusetts General Hospital. Case 34-2011: A 75-year-old man with memory loss and partial seizures.
Cash SS; Larvie M; Dalmau J
N Engl J Med; 2011 Nov; 365(19):1825-33. PubMed ID: 22070480
[No Abstract] [Full Text] [Related]
17. Seizure control and cognitive improvement via immunotherapy in late onset epilepsy patients with paraneoplastic versus GAD65 autoantibody-associated limbic encephalitis.
Hansen N; Widman G; Witt JA; Wagner J; Becker AJ; Elger CE; Helmstaedter C
Epilepsy Behav; 2016 Dec; 65():18-24. PubMed ID: 27855355
[TBL] [Abstract][Full Text] [Related]
18. Seronegative autoimmune encephalitis: clinical characteristics and factors associated with outcomes.
Lee WJ; Lee HS; Kim DY; Lee HS; Moon J; Park KI; Lee SK; Chu K; Lee ST
Brain; 2022 Oct; 145(10):3509-3521. PubMed ID: 35512357
[TBL] [Abstract][Full Text] [Related]
19. [Autoimmune synaptic encephalopathies].
Friese MA; Magnus T
Nervenarzt; 2011 Oct; 82(10):1239-49. PubMed ID: 21424416
[TBL] [Abstract][Full Text] [Related]
20. Predictive models in the diagnosis and treatment of autoimmune epilepsy.
Dubey D; Singh J; Britton JW; Pittock SJ; Flanagan EP; Lennon VA; Tillema JM; Wirrell E; Shin C; So E; Cascino GD; Wingerchuk DM; Hoerth MT; Shih JJ; Nickels KC; McKeon A
Epilepsia; 2017 Jul; 58(7):1181-1189. PubMed ID: 28555833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
